Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project (Q37384289)
Jump to navigation
Jump to search
scientific article published on 20 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project |
scientific article published on 20 July 2015 |
Statements
1 reference
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project (English)
1 reference
Ranjana H Advani
1 reference
Steven M Horwitz
1 reference
Richard T Hoppe
1 reference
Youn H Kim
1 reference
Mahkam Tavallaee
1 reference
Uma Sundram
1 reference
Katrin A Salva
1 reference
Gary S Wood
1 reference
Shufeng Li
1 reference
Sima Rozati
1 reference
Seema Nagpal
1 reference
Michael Krathen
1 reference
Sunil Reddy
1 reference
Annie Nguyen-Lin
1 reference
Wen-Kai Weng
1 reference
Randall Armstrong
1 reference
Melissa Pulitzer
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference